vs
IDEAYA Biosciences, Inc.（IDYA）与Organogenesis Holdings Inc.（ORGO）财务数据对比。点击上方公司名可切换其他公司
Organogenesis Holdings Inc.的季度营收约是IDEAYA Biosciences, Inc.的1.1倍（$225.6M vs $207.8M），IDEAYA Biosciences, Inc.净利率更高（57.4% vs 19.4%，领先38.0%），IDEAYA Biosciences, Inc.自由现金流更多（$142.2M vs $34.8M）
IDEAYA Biosciences是一家临床阶段生物技术企业，专注于肿瘤学领域，研发针对基因定义癌症的靶向疗法及合成致死治疗方案，推进多肿瘤类型的候选药物管线开发，与行业伙伴合作提升全球创新癌症治疗方案的可及性。
Organogenesis Holdings Inc.是一家领先的再生医学企业，专注于开发、生产用于伤口护理、外科修复、运动医学和皮肤病领域的先进治疗产品，主要服务美国及部分国际市场的医疗机构与患者，提供经临床验证的医疗解决方案。
IDYA vs ORGO — 直观对比
营收规模更大
ORGO
是对方的1.1倍
$207.8M
净利率更高
IDYA
高出38.0%
19.4%
自由现金流更多
IDYA
多$107.4M
$34.8M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $207.8M | $225.6M |
| 净利润 | $119.2M | $43.7M |
| 毛利率 | — | — |
| 营业利润率 | 52.2% | 28.1% |
| 净利率 | 57.4% | 19.4% |
| 营收同比 | — | 78.1% |
| 净利润同比 | 330.1% | 469.5% |
| 每股收益（稀释后） | $1.33 | $0.31 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IDYAORGO
| Q4 25 | — | $225.6M | ||
| Q3 25 | $207.8M | $150.9M | ||
| Q2 25 | — | $101.0M | ||
| Q1 25 | — | $86.7M | ||
| Q4 24 | — | $126.7M | ||
| Q3 24 | $0 | $115.2M | ||
| Q2 24 | $0 | $130.2M | ||
| Q1 24 | $0 | $110.0M |
净利润IDYAORGO
| Q4 25 | — | $43.7M | ||
| Q3 25 | $119.2M | $21.6M | ||
| Q2 25 | — | $-9.4M | ||
| Q1 25 | — | $-18.8M | ||
| Q4 24 | — | $7.7M | ||
| Q3 24 | $-51.8M | $12.3M | ||
| Q2 24 | $-52.8M | $-17.0M | ||
| Q1 24 | $-39.6M | $-2.1M |
毛利率IDYAORGO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 72.6% | ||
| Q4 24 | — | 75.5% | ||
| Q3 24 | — | 76.7% | ||
| Q2 24 | — | 77.6% | ||
| Q1 24 | — | 73.9% |
营业利润率IDYAORGO
| Q4 25 | — | 28.1% | ||
| Q3 25 | 52.2% | 13.7% | ||
| Q2 25 | — | -12.5% | ||
| Q1 25 | — | -30.9% | ||
| Q4 24 | — | 8.1% | ||
| Q3 24 | — | 5.4% | ||
| Q2 24 | — | -10.7% | ||
| Q1 24 | — | -3.5% |
净利率IDYAORGO
| Q4 25 | — | 19.4% | ||
| Q3 25 | 57.4% | 14.3% | ||
| Q2 25 | — | -9.3% | ||
| Q1 25 | — | -21.7% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | — | 10.7% | ||
| Q2 24 | — | -13.1% | ||
| Q1 24 | — | -1.9% |
每股收益（稀释后）IDYAORGO
| Q4 25 | — | $0.31 | ||
| Q3 25 | $1.33 | $0.11 | ||
| Q2 25 | — | $-0.10 | ||
| Q1 25 | — | $-0.17 | ||
| Q4 24 | — | $0.05 | ||
| Q3 24 | $-0.60 | $0.09 | ||
| Q2 24 | $-0.68 | $-0.13 | ||
| Q1 24 | $-0.53 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $786.9M | $93.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.1B | $300.1M |
| 总资产 | $1.2B | $598.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IDYAORGO
| Q4 25 | — | $93.7M | ||
| Q3 25 | $786.9M | $63.7M | ||
| Q2 25 | — | $73.1M | ||
| Q1 25 | — | $110.0M | ||
| Q4 24 | — | $135.6M | ||
| Q3 24 | $920.0M | $94.3M | ||
| Q2 24 | $701.7M | $89.9M | ||
| Q1 24 | $698.8M | $88.6M |
总债务IDYAORGO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $62.3M | ||
| Q2 24 | — | $63.8M | ||
| Q1 24 | — | $65.2M |
股东权益IDYAORGO
| Q4 25 | — | $300.1M | ||
| Q3 25 | $1.1B | $255.1M | ||
| Q2 25 | — | $233.2M | ||
| Q1 25 | — | $242.9M | ||
| Q4 24 | — | $262.9M | ||
| Q3 24 | $1.2B | $278.5M | ||
| Q2 24 | $931.7M | $263.5M | ||
| Q1 24 | $935.3M | $278.0M |
总资产IDYAORGO
| Q4 25 | — | $598.7M | ||
| Q3 25 | $1.2B | $509.8M | ||
| Q2 25 | — | $461.1M | ||
| Q1 25 | — | $467.4M | ||
| Q4 24 | — | $497.9M | ||
| Q3 24 | $1.2B | $446.3M | ||
| Q2 24 | $973.7M | $443.2M | ||
| Q1 24 | $961.5M | $458.5M |
负债/权益比IDYAORGO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.22× | ||
| Q2 24 | — | 0.24× | ||
| Q1 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $142.2M | $39.4M |
| 自由现金流经营现金流 - 资本支出 | $142.2M | $34.8M |
| 自由现金流率自由现金流/营收 | 68.4% | 15.4% |
| 资本支出强度资本支出/营收 | 0.0% | 2.1% |
| 现金转化率经营现金流/净利润 | 1.19× | 0.90× |
| 过去12个月自由现金流最近4个季度 | $13.5M | $-24.5M |
8季度趋势，按日历期对齐
经营现金流IDYAORGO
| Q4 25 | — | $39.4M | ||
| Q3 25 | $142.2M | $3.1M | ||
| Q2 25 | — | $-32.9M | ||
| Q1 25 | — | $-19.9M | ||
| Q4 24 | — | $10.9M | ||
| Q3 24 | $-49.2M | $8.7M | ||
| Q2 24 | $-32.9M | $4.7M | ||
| Q1 24 | $-43.8M | $-10.2M |
自由现金流IDYAORGO
| Q4 25 | — | $34.8M | ||
| Q3 25 | $142.2M | $844.0K | ||
| Q2 25 | — | $-36.5M | ||
| Q1 25 | — | $-23.6M | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | $-49.7M | $6.1M | ||
| Q2 24 | $-33.9M | $2.9M | ||
| Q1 24 | $-45.1M | $-12.4M |
自由现金流率IDYAORGO
| Q4 25 | — | 15.4% | ||
| Q3 25 | 68.4% | 0.6% | ||
| Q2 25 | — | -36.1% | ||
| Q1 25 | — | -27.2% | ||
| Q4 24 | — | 6.0% | ||
| Q3 24 | — | 5.3% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | — | -11.3% |
资本支出强度IDYAORGO
| Q4 25 | — | 2.1% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | — | 3.6% | ||
| Q1 25 | — | 4.2% | ||
| Q4 24 | — | 2.7% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 2.0% |
现金转化率IDYAORGO
| Q4 25 | — | 0.90× | ||
| Q3 25 | 1.19× | 0.14× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.43× | ||
| Q3 24 | — | 0.71× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
